Kristian Humer
Chief Financial Officer at 4D Molecular Therapeutics, Inc. (FDMT) since December 2025
Kristian Humer has filed 18 insider reports with the SEC since July 2021, as chief Financial Officer at 4D Molecular Therapeutics, Inc. (FDMT), chief Financial Officer at Foghorn Therapeutics Inc. (FHTX) and director at Sensei Biotherapeutics, Inc. (FTH) and at 1 more company. The latest filing, on December 11, 2025, reports grant or award at 4D Molecular Therapeutics, Inc. (FDMT).
- Filings
- 18
- Companies
- 4
- Bought on market
- None
- Sold on market
- None
Companies where Kristian Humer is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince December 2025 | $10.23 | Dec 11, 2025 | |||||
| Chief Financial Officersince April 2024 | $1.72 | Nov 17, 2025 | |||||
| Directorsince July 2021 | 8,932 | $7.88 | May 23, 2025 | ||||
| Officersince July 2021 | $29.96 | Feb 10, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Dec 9, 2025FDMTSEC Form 4 filed by Chief Financial Officer Humer KristianForm 4Grant or award
- Dec 9, 2025FDMTKristian Humer became an insiderForm 3New insider
- Nov 17, 2025FHTXSEC Form 4 filed by Chief Financial Officer Humer KristianForm 4
- May 21, 2025FTHSEC Form 4 filed by Director Humer KristianForm 4Grant or award
- Jan 22, 2025FHTXSEC Form 4 filed by Chief Financial Officer Humer KristianForm 4Grant or award
- Jun 11, 2024FTHSEC Form 4 filed by Director Humer KristianForm 4Grant or award
- Apr 16, 2024FHTXSEC Form 4 filed by Humer KristianForm 4Grant or award
- Apr 16, 2024FHTXKristian Humer became an insiderForm 3New insider
- Jul 10, 2023FTHSEC Form 4 filed by Humer KristianForm 4Grant or award
- Feb 8, 2023VRDNSEC Form 4 filed by Humer KristianForm 4Grant or award
- Jun 10, 2022FTHSEC Form 4: Humer Kristian was granted 4,466 sharesForm 4Grant or award
- Feb 2, 2022VRDNSEC Form 4 filed by Humer KristianForm 4Grant or award
- Dec 31, 2021VRDNSEC Form 4 filed by Humer KristianForm 4Grant or award
- Jul 30, 2021FTHSEC Form 4 filed by Humer KristianForm 4Grant or award
- Jul 30, 2021FTHSEC Form 3 filed by Humer KristianForm 3New insider
- Jul 26, 2021VRDNSEC Form 4 filed by Humer KristianForm 4Grant or award
- Jul 26, 2021VRDNSEC Form 3 filed by Humer KristianForm 3New insider
- Jul 26, 2021VRDNSEC Form 3 filed by Humer KristianForm 3New insider
Compare Kristian Humer with
- Kristian Humer vs Anand Kiran Parikh1 shared
- Kristian Humer vs Scott Bizily1 shared
- Kristian Humer vs David Kirn1 shared
- Kristian Humer vs Karen H Vousden1 shared
- Kristian Humer vs Jennifer Tousignant1 shared
- Kristian Humer vs Radhika Tripuraneni1 shared
Other insiders at the same companies
- Anand Kiran ParikhFTH
- Scott BizilyFDMT
- David KirnFDMT
- Karen H VousdenFTH
- Jennifer TousignantVRDN
- Radhika TripuraneniVRDN
- Khosla Ventures VI, L.P.FTH
- Josiah CraverFTH
- Sarah GheuensVRDN
- Arlene MorrisVRDN
- Tomas KiselakVRDN
- Jeffrey Robert AjerVRDN
- Jennifer K. MosesVRDN
- Christopher W. CainVRDN
- Brian C StephensonFTH
- Thomas J. Lynch Jr.FHTX
Questions about Kristian Humer
- What is Kristian Humer's role at 4D Molecular Therapeutics, Inc.?
- Kristian Humer reports to the SEC as chief Financial Officer at 4D Molecular Therapeutics, Inc. (FDMT), according to the latest filing on December 11, 2025. Kristian Humer has also filed as chief Financial Officer at Foghorn Therapeutics Inc. (FHTX), director at Sensei Biotherapeutics, Inc. (FTH) and officer at Viridian Therapeutics, Inc.\DE (VRDN).
- How many shares does Kristian Humer own?
- After the latest filing that states it, Kristian Humer directly owned 8,932 shares of Sensei Biotherapeutics, Inc. (FTH). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Kristian Humer bought or sold stock recently?
- No open-market purchases or sales by Kristian Humer are on file. The filings report grant or award.
- How do I get alerts when Kristian Humer files?
- Follow Kristian Humer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Kristian Humer (SEC CIK 0001872280). Totals count each trade once, skipping amendments whose original is on file, from Jul 27, 2021 on. View on SEC EDGAR · Get this as JSON